# Aleve

NDC: 70264-011
Generic name: NAPROXEN SODIUM
Labeler / Manufacturer: R J General Corporation
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20140226

FDA application: NDA020204

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70264-011"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70264-011
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46e7b298-9e19-49b6-be71-e4fdcb09a5d4